FDA Investigator Ethan P Stegman

Ethan P Stegman has conducted inspections on 151 sites in 16 countries as of 18 Sep 2019. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
151
Last Inspection Date:
18 Sep 2019
Investigator Role:
FDA Investigator
Redica ID:
100000591
Countries of Inspections:
United States of America, Italy, Canada, Romania, Finland, Puerto Rico, Chile, Belgium, Spain, Malaysia, India, Peru, France, Austria, Ukraine, Denmark
FDA Investigators that have inspected at least one site in common with Ethan P Stegman:
Albert A Salvador, Alec D Fabus, Ana Delp Cintron, Ana P Barido, Angela E Glenn, Annette Melendez, Ashley B Jelonek, Ashley Gonzalez, Barbara D Wright, Barbara T Carmichael, Bill Tacket, Jr, Billy M Battles, Bonita S Chester, Brant M Schroeder, Bruce Quijano, Brunilda Torres, Byungja E Marciante, Carl Lee, CDR Ileana Barreto Pettit, CDR Sean T Creighton, Chantae D Mitchell, Charles S Watson, Chinyere A Asanya, Chyla T Hunter, Clara E Santiago, Colleen M Aspinwall, Courtney A Gilbert, Courtney Hunt, Craig A Garmendia, Cynthia F Kleppinger, MD, Daniel C Skirvin, David M Pearson, David P King, Delkis J Caycedo, Dianiris C Ayala, Dillard H Woody, Jr, Donald J Mee, Doretha M Wilson, Dusty F Snoeberg, Edwin J Gorney, Eileen T Monaghan, Emily A Baldwin, Eric R Holm, Ernest A Clausnitzer, Ernest L Levins, Frances M Rivera, Gene R Gunn, German Rivera, Gideon N Esuzor, Gina Eng, Glenn S Quintanilla, Harry R Bringger, Jr, Holly M Scott, Ivan E Reyes, James P Mcevoy, Jana L Caylor, Jason P Aun, Jennifer A Robinson, Jennifer L Huntington, Jennifer M Menendez, Jessica L Pressley, Joanne E King, Jolanna A Norton, Jontae D Sanders, Jose R Rodriguez, Karen M Cooper, Karl D Hezel, Kassa Ayalew, MD, Kathryn Suttling, Kayla V Sprague, Keith A Schwartz, Kimberly A Dux, Lakecha N Lewis, Laura E Garcia, LCDR Angelica M Chica, LCDR Margaret Edi Gennaro, LCDR Michael H Tollon, LCDR Randall L Morris, Leroy Terrelonge, Leslie A Cartmill, Linda K Matheny, Lindsay R Hatch, Lisa K Capron, Lori A Gioia, LT Tamara J Henderson, Lura D Baquero, Lura D Kelly, Luz I Collado, Marc Balzarini, Mary F Bodick, Matthew B Thomaston, Michelle S Dunaway, Min Lu, Minerva Rogers, Mizanne E Lewis, Nerming V Briones, Nicole E Knowlton, Ormond, Paul A Licata, Paul H Dakin, Rachel A Peters, Raymond A Lyn, Jr, Reynolds, Richard W Berning, Ronan F King, Ronnie E Jackson, Samantha J Pinizzotto, D V M, Scott A Jepson, Sergio E Delgado, Sharon Giamberini, Shavon L Square, Sherbet L Samuels, Sheri L Stephenson, Siramad Sainz Trujillo, Stacey F Allard, Stephen T Hansen, Susan M Corrales, Susan M Turcovski, Tajah L Blackburn, Thai D Truong, Tracy L Reed, Valerie Jgrecek Trinh, Victor Spanioli, Yazmith Guzman

Ethan P Stegman's Documents

Publish Date Document Type Title
December, 2013 FDA 483 Response Boca Pharmacal Inc. - Form 483R, 2014-01-03
August, 2009 FDA 483 Andapharm, LLC - Form 483, 2009-08-07
February, 2011 FDA 483 Asset Holdings Group, Inc. - Form 483, 2011-02-18
February, 2010 FDA 483 Perrigo Florida Inc - Form 483, 2010-02-11
February, 2010 FDA 483 Perrigo Florida, Inc - Form 483, 2010-02-11
November, 2018 FDA 483 Prof Dr Eva Maria Maida - Form 483, 2018-11-02
September, 2015 FDA 483 Visions Clinical Research - Form 483, 2015-09-11
December, 2013 EIR Boca Pharmacal Inc. - EIR, 2013-12-30
September, 2015 EIR Visions Clinical Research - EIR, 2015-09-11
August, 2014 FDA 483 Dr. Maria Elena Santolaya de Pablo - Form 483, 2014-08-22
May, 2017 EIR Comprehensive Clinical Research, LLC - EIR, 2017-05-25
October, 2010 EIR Rexall Sundown Inc. - EIR, 2010-10-27
May, 2019 FDA 483 Jeanne-Elyse G. Cedeno, M.D. - Form 483, 2019-05-30
February, 2017 EIR Guillermo Valenzuela, MD - EIR, 2017-02-09
September, 2011 FDA 483 Infupharma LLC d.b.a. President Pharmacy - Form 483, 2011-09-27
November, 2017 FDA 483 Amparo Sole Jover, M.D. - Form 483, 2017-11-17
January, 2009 FDA 483 Perrigo Florida Inc - Form 483, 2009-01-27
September, 2011 FDA 483 Response Infupharma LLC d.b.a. President Pharmacy - Form 483R, 2011-10-10
November, 2019 FDA 483 Jennifer C. Bartczak, M.D. - Form 483, 2019-11-06

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more